Robert L. Dana - Comment

Document ID: FDA-2009-N-0435-0016
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 04 2010, at 12:46 PM Eastern Standard Time
Date Posted: February 4 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: November 10 2009, at 12:00 AM Eastern Standard Time
Comment Due Date: February 5 2010, at 11:59 PM Eastern Standard Time
Tracking Number: 80a8dd89
View Document:

This is comment on Proposed Rule

Current Good Manufacturing Practice Requirements for Combination Products; Extension of Comment Period

View Comment

On behalf of the Parenteral Drug Association, we are pleased to present comments on 21 CFR Part 4, "Current Good Manufacturing Practice Requirements for Combination Products" (Docket No. f/k/a FDA-2008-D-0409) [extension for comment period, Docket ID FDA-2009-N-0435-004].

Related Comments

View All

Total: 17

Novo Nordisk, Inc. - Comment
Public Submission Posted: 01/26/2010 ID: FDA-2009-N-0435-0009